Induction of Multi-Functional T Cells in a Phase I Clinical Trial of Dendritic Cell Immunotherapy in Hepatitis C Virus Infected Individuals
Shuo Li, Stuart Roberts, Magdalena Plebanski, Maelenn Gouillou, Tim Spelman, Philippe Latour, David Jackson, Lorena Brown, Rosemary L Sparrow, H Miles Prince, Derek Hart, Bruce E Loveland, Eric J Gowans
PLoS One | PUBLIC LIBRARY SCIENCE | Published : 2012
Related Projects (1)
Awarded by National Health and Medical Research Council (NHMRC) of Australia
Awarded by National Institutes of Health
The funding for this work was provided by grants from 1. National Health and Medical Research Council (NHMRC) of Australia, ID 433908; 2. National Institutes of Health RO1A1054459; and 3. Private donations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.The authors thank Calum de Burgh (University of Aberdeen, UK) for general technical assistance; Laurie Lamoreaux (Vaccine Research Centre, NIH) for critical advice on data interpretation; and Geza Paukovics (Burnet Institute) for assistance in flow cytometry. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. EJG is a recipient of a NHMRC Senior Research Fellow award. The following reagent was obtained through BEI Resources, NIAID, NIH: Peptide Arrays for Hepatitis C Virus H77.